570-30-9 Usage
Uses
Used in Pharmaceutical Industry:
1,3,5(10)-ESTRATRIEN-3,15-ALPHA, 17-BETA-TRIOL is used as a pharmaceutical compound for its potential therapeutic effects. Due to its structural similarity to estrogen, it may have applications in hormone replacement therapy or the treatment of hormone-related conditions.
Used in Cosmetic Industry:
1,3,5(10)-ESTRATRIEN-3,15-ALPHA, 17-BETA-TRIOL is used as an ingredient in cosmetic products for its potential anti-aging and skin rejuvenation properties. Its estrogen-like activity may contribute to improved skin elasticity and reduced signs of aging.
Used in Research Applications:
1,3,5(10)-ESTRATRIEN-3,15-ALPHA, 17-BETA-TRIOL is used as a research compound for studying the effects of estrogen-like substances on various biological processes. It may be employed in experiments to investigate the mechanisms of hormone action and develop new therapeutic strategies for hormone-related disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 570-30-9 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,7 and 0 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 570-30:
(5*5)+(4*7)+(3*0)+(2*3)+(1*0)=59
59 % 10 = 9
So 570-30-9 is a valid CAS Registry Number.
InChI:InChI=1/C18H24O3/c1-18-7-6-13-12-5-3-11(19)8-10(12)2-4-14(13)17(18)15(20)9-16(18)21/h3,5,8,13-17,19-21H,2,4,6-7,9H2,1H3/t13-,14-,15+,16+,17-,18-/m1/s1
570-30-9Relevant academic research and scientific papers
Microbial hydroxylation of 17β-estradiol by Penicillium brevicompactum
Shan, Lihong,Li, Yang,Chen, Yanjie,Yin, Minghui,Huang, Jiajia,Zhang, Zhenzhong,Shi, Xiufang,Liu, Hongmin
, p. 137 - 143 (2016/12/16)
Microbial hydroxylation of 17β-estradiol (1) with Penicillium brevicompactum, a fungal species not used in biotransformation so far, yielded four metabolites: 1, 3, 5-estratriene-3, 15α-diol-17-one (2); 1, 3, 5-estratriene-3, 6α, 17β-triol (3); 1, 3, 5-estratriene-3, 15α, 17β-triol (4); and 1, 3, 5-estratriene-3, 6α, 15α-triol-17-one (5). All the products were determined by 1H NMR, 13C NMR, two-dimensional NMR, and HRMS techniques. Compounds 3, 4, and 5 are reported for the first time via microbial transformation, and 5 is a new compound as far as we know. Possible metabolic pathway of 17β-estradiol via Penicillium brevicompactum was also proposed.
